Premium
XTL Biopharmaceuticals Ltd (XTLB)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjo... XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren’s syndrome. The company has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.4 | -16.2601626016 | 2.46 | 2.51 | 2.04 | 10386 | 2.33942309 | DR |
| 4 | -0.64 | -23.7037037037 | 2.7 | 2.935 | 2.04 | 30157 | 2.57995619 | DR |
| 12 | 1.413 | 218.392581144 | 0.647 | 4.87 | 0.556 | 2052130 | 3.554586 | DR |
| 26 | 1.2139 | 143.470039002 | 0.8461 | 4.87 | 0.5301 | 1311600 | 2.88079282 | DR |
| 52 | 0.84 | 68.8524590164 | 1.22 | 4.87 | 0.5301 | 839433 | 2.64565537 | DR |
| 156 | 0.84 | 68.8524590164 | 1.22 | 4.9897 | 0.5301 | 350111 | 2.63022617 | DR |
| 260 | -1.52 | -42.4581005587 | 3.58 | 6.69 | 0.5301 | 221768 | 2.69861547 | DR |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
